Added to YB: 2026-10-09
Pitch date: 2026-10-05
NRXS [bullish]
NeurAxis, Inc.
+7.5%
current return
Author Info
Microcap Opportunities is a community dedicated to finding the best opportunities in the MicroCap space for US and Canadian listings primarily. Sign up for the newsletter.
Company Info
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
Market Cap
$85.1M
Pitch Price
$7.20
Price Target
37.00 (+378%)
Dividend
N/A
EV/EBITDA
-10.27
P/E
-8.74
EV/Sales
14.50
Sector
Health Care Equipment and Supplies
Category
growth
We Are Now Fully Focused on Multibaggers - NeurAxis, Inc.
NRXS (hold): NeurAxis’s FDA-cleared, non-drug therapy for pediatric abdominal pain now has roughly 120 million commercially covered lives, with two large payers pending. The stated 4–5x case from $7.43 implies $30–37: a full-day program at a large pediatric hospital could generate $2 million annually, requiring only a few dozen programs. Sales capacity is expanding to convert coverage into programs; the path is described as credible.
Read full article (1 min)